(Q40179544)

18 September 2017

title

A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells (English)

1 reference

18 September 2017

1 reference

Marzio G

1

1 reference

18 September 2017

Kerkvliet E

2

1 reference

18 September 2017

Bogaards JA

3

1 reference

18 September 2017

Koelewijn S

4

1 reference

18 September 2017

De Groot A

5

1 reference

18 September 2017

Gijsbers L

6

1 reference

18 September 2017

Weverling GJ

7

1 reference

18 September 2017

Vogels R

8

1 reference

18 September 2017

Havenga M

9

1 reference

18 September 2017

Custers J

10

1 reference

18 September 2017

Pau MG

11

1 reference

18 September 2017

Guichoux JY

12

1 reference

18 September 2017

Lewis J

13

1 reference

18 September 2017

Goudsmit J

14

1 reference

18 September 2017

language of work or name

English

0 references

publication date

28 December 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

25

1 reference

18 September 2017

issue

12

1 reference

18 September 2017

page(s)

2228-2237

1 reference

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Biosafety of adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Development of adenovirus serotype 35 as a gene transfer vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.011

10.1016/J.VACCINE.2006.12.011

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference